| scholarly article | Q13442814 |
| P2093 | author name string | Nathalie Ortega | |
| Jean Plouët | |||
| Helen Hutchings | |||
| P2860 | cites work | The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. | Q40241912 |
| Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. | Q40822298 | ||
| Direct cell adhesion to the angiopoietins mediated by integrins | Q43603092 | ||
| The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency | Q44317160 | ||
| Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. | Q52553091 | ||
| Extracellular Matrix-derived Peptide Binds to αvβ3Integrin and Inhibits Angiogenesis | Q58214922 | ||
| Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins | Q61631829 | ||
| A mechanism for modulation of cellular responses to VEGF: activation of the integrins | Q64380279 | ||
| Quantification of cells cultured on 96-well plates | Q69413909 | ||
| Autocrine regulation of bovine retinal capillary endothelial cell (BREC) proliferation by BREC-derived basic fibroblast growth factor | Q69627589 | ||
| Xenografts of human solid tumors frequently express cellular-associated isoform of vascular endothelial growth factor (VEGF) 189 | Q73088081 | ||
| Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer | Q73513573 | ||
| Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor | Q73717921 | ||
| The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage | Q73880328 | ||
| Identification of an alpha(3)beta(1) integrin recognition sequence in thrombospondin-1 | Q78122317 | ||
| Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. | Q22008760 | ||
| Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor | Q24294262 | ||
| Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor | Q24321564 | ||
| The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor | Q24328901 | ||
| Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1 | Q24644444 | ||
| The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis | Q28137622 | ||
| Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected] | Q28140705 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| The biology of vascular endothelial growth factor | Q29615946 | ||
| Activation of Rac and Cdc42 by integrins mediates cell spreading | Q29616113 | ||
| Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels | Q29619679 | ||
| Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans | Q33902687 | ||
| Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 | ||
| Tumstatin, an endothelial cell-specific inhibitor of protein synthesis | Q34107979 | ||
| Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms | Q34787725 | ||
| Integrin-mediated signals regulated by members of the rho family of GTPases | Q36256316 | ||
| Simultaneous measurement of cell cycle and apoptotic cell death | Q36897369 | ||
| alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells | Q38615044 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| biotechnology | Q7108 | ||
| genetics | Q7162 | ||
| endothelium | Q111140 | ||
| cell adhesion | Q187640 | ||
| extracellular matrix | Q193825 | ||
| P304 | page(s) | 1520-1522 | |
| P577 | publication date | 2003-04-22 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation | |
| Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation | |||
| P478 | volume | 17 |
| Q34197864 | A triad of lys12, lys41, arg78 spatial domain, a novel identified heparin binding site on tat protein, facilitates tat-driven cell adhesion |
| Q37515471 | An integrated micro-electro-fluidic and protein arraying system for parallel analysis of cell responses to controlled microenvironments |
| Q40490472 | Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway |
| Q50239732 | Astrocytes spatially restrict VEGF signaling by polarized secretion and incorporation of VEGF into the actively assembling extracellular matrix |
| Q36542090 | Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion |
| Q41912624 | Beneficial effect of mechanical stimulation on the regenerative potential of muscle-derived stem cells is lost by inhibiting vascular endothelial growth factor. |
| Q47546891 | Beyond the Matrix: The Many Non-ECM Ligands for Integrins. |
| Q38004962 | Bioactive polymer scaffold for fabrication of vascularized engineering tissue. |
| Q41601067 | Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma |
| Q35951999 | Collagen VI ablation retards brain tumor progression due to deficits in assembly of the vascular basal lamina |
| Q47983641 | Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis |
| Q37928833 | Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix |
| Q36245636 | Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan |
| Q37086277 | Emerging pulmonary vasculature lacks fate specification |
| Q34087039 | Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF. |
| Q42119488 | Endothelial cell phenotypic behaviors cluster into dynamic state transition programs modulated by angiogenic and angiostatic cytokines |
| Q48595604 | Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth |
| Q55368051 | Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds. |
| Q42581018 | Extracellular matrix stiffness modulates VEGF calcium signaling in endothelial cells: individual cell and population analysis |
| Q41990778 | Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton |
| Q83095845 | Functional VEGF haplotypes affect the susceptibility to hypertension |
| Q33809311 | Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE- and SSCE-MRI. |
| Q55342743 | Genistein modulates the estrogen receptor and suppresses angiogenesis and inflammation in the murine model of peritoneal endometriosis. |
| Q34548765 | Growth factor delivery-based tissue engineering: general approaches and a review of recent developments |
| Q35976714 | Human apolipoprotein(a) kringle V inhibits ischemia-induced retinal neovascularization via suppression of fibronectin-mediated angiogenesis |
| Q37091356 | In Vitro Endothelialization of Biodegradable Vascular Grafts Via Endothelial Progenitor Cell Seeding and Maturation in a Tubular Perfusion System Bioreactor |
| Q38878644 | Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma |
| Q37190487 | Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression |
| Q24297946 | Inhibition of β1 integrin and IL-3Rβ common subunit interaction hinders tumour angiogenesis |
| Q46220745 | Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis |
| Q38501776 | Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation |
| Q41630032 | Integrins and p53 pathways in glioblastoma resistance to temozolomide |
| Q33591910 | Integrins as "functional hubs" in the regulation of pathological angiogenesis |
| Q24629255 | International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy |
| Q37590219 | Interplay between cell adhesion and growth factor receptors: from the plasma membrane to the endosomes |
| Q35574990 | Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells |
| Q38634403 | Localization of VEGF to Vascular ECM Is an Important Aspect of Tumor Angiogenesis |
| Q24294441 | MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway |
| Q82415696 | Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1 |
| Q30160213 | Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes |
| Q34089123 | Molecular diversity of VEGF-A as a regulator of its biological activity. |
| Q36636355 | Molecular mechanisms of VEGF-A action during tissue repair |
| Q36552576 | NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression |
| Q35799099 | NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization |
| Q30570375 | Netrin-4 promotes mural cell adhesion and recruitment to endothelial cells. |
| Q35534079 | Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions. |
| Q36357421 | Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels |
| Q35218162 | P2Y2 nucleotide receptor mediates arteriogenesis in a murine model of hind limb ischemia |
| Q35087922 | Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair |
| Q24678647 | Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors |
| Q33649673 | Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model |
| Q38156623 | Role of Angptl4 in vascular permeability and inflammation |
| Q24295052 | Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis |
| Q64252943 | Shedding New Light on The Role of ανβ3 and α5β1 Integrins in Rheumatoid Arthritis |
| Q42567361 | Single and combined effects of alphavbeta3- and alpha5beta1-integrins on capillary tube formation in a human fibrinous matrix |
| Q33787955 | Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis) |
| Q37728355 | Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad |
| Q36918137 | Synovial fibroblasts spread rheumatoid arthritis to unaffected joints |
| Q42367752 | Synthetic microparticles conjugated with VEGF165 improve the survival of endothelial progenitor cells via microRNA-17 inhibition |
| Q45740855 | Targeting Heparin to Collagen within Extracellular Matrix Significantly Reduces Thrombogenicity and Improves Endothelialization of Decellularized Tissues |
| Q41986585 | The Role of the Endothelium in HPS Pathogenesis and Potential Therapeutic Approaches |
| Q37565247 | The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model |
| Q36390431 | The role of VEGF receptors in angiogenesis; complex partnerships |
| Q35706345 | Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells |
| Q34385843 | Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. |
| Q37953773 | Tumor angiogenesis: molecular pathways and therapeutic targets |
| Q35765454 | Tumor stroma derived biomarkers in cancer |
| Q47123466 | Tumstatin regulates the angiogenic and inflammatory potential of airway smooth muscle extracellular matrix |
| Q35688115 | VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. |
| Q40472491 | VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. |
| Q36949564 | VEGF: an essential mediator of both angiogenesis and endochondral ossification |
| Q34488846 | Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site |
| Q39153235 | Vascular endothelial growth factor induces CXCL1 chemokine release via JNK and PI-3K-dependent pathways in human lung carcinoma epithelial cells |
| Q37745063 | Vascularization Potential of Electrospun Poly(L-Lactide-co-Caprolactone) Scaffold: The Impact for Tissue Engineering. |
| Q91899256 | α4β1 integrin associates with VEGFR2 in CLL cells and contributes to VEGF binding and intracellular signaling |
| Q26851768 | αV integrins in angiogenesis and cancer |
Search more.